AIM ImmunoTech (AIM) Interest Coverage Ratio (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Interest Coverage Ratio came in at 2.23 in Q1 2026, up 87.92% YoY from 1.19 in Q1 2025, and up 78.69% on a QoQ basis from 10.47 in Q4 2025.
AIM ImmunoTech (AIM) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Interest Coverage Ratio data on file, last reported at 2.23 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 87.92% year-over-year to 2.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.29 (up 88.58% YoY) and the FY2025 annual result came in at 0.25, up 46.01% from the prior year.
- Interest Coverage Ratio advanced to 2.23 in Q1 2026, from 10.47 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.16 in Q2 2025 to a low of 102.22 in Q4 2023.
- A 5-year average of 25.79 and a median of 19.56 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio jumped 94.87% — and 2025, when it plunged 728.54%.
- Tracing AIM's Interest Coverage Ratio over 5 years: stood at 72.16 in 2022, then tumbled by 41.66% to 102.22 in 2023, then jumped by 56.61% to 44.36 in 2024, then soared by 76.4% to 10.47 in 2025, then jumped by 78.69% to 2.23 in 2026.
- The last three Interest Coverage Ratio figures came in at 2.23 (Q1 2026), 10.47 (Q4 2025), and 13.02 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.42 |
| 10 | AIM ImmunoTech | 4.42 Mn | -5.54 Mn | 21,000.00 | -11.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.97 |
| Mar 31, 2026 | -2.23 |
| Dec 31, 2025 | -10.47 |
| Sep 30, 2025 | -13.02 |
| Jun 30, 2025 | -1.16 |
| Mar 31, 2025 | -18.46 |
| Dec 31, 2024 | -44.36 |
| Sep 30, 2024 | -20.50 |
| Jun 30, 2024 | -1.40 |
| Mar 31, 2024 | -2.23 |
| Dec 31, 2023 | -102.22 |
| Sep 30, 2023 | -40.79 |
| Jun 30, 2023 | -27.31 |
| Mar 31, 2023 | -21.48 |
| Dec 31, 2022 | -72.16 |
| Sep 30, 2022 | -27.75 |
| Jun 30, 2022 | -19.56 |
| Mar 31, 2022 | -13.41 |
| Sep 30, 2021 | -3.49 |
| Jun 30, 2021 | -3.81 |